Compare NTRA & UI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | UI |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9B | 33.3B |
| IPO Year | 2015 | 2011 |
| Metric | NTRA | UI |
|---|---|---|
| Price | $231.21 | $553.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 2 |
| Target Price | $249.53 | ★ $587.50 |
| AVG Volume (30 Days) | ★ 1.1M | 99.7K |
| Earning Date | 02-26-2026 | 02-06-2026 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | N/A | ★ 102.50 |
| EPS | N/A | ★ 13.07 |
| Revenue | $2,116,676,000.00 | ★ $2,756,974,000.00 |
| Revenue This Year | $33.77 | $15.91 |
| Revenue Next Year | $16.92 | $9.19 |
| P/E Ratio | ★ N/A | $43.34 |
| Revenue Growth | ★ 38.17 | 36.77 |
| 52 Week Low | $125.38 | $255.00 |
| 52 Week High | $256.36 | $803.60 |
| Indicator | NTRA | UI |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 46.75 |
| Support Level | $229.14 | $525.71 |
| Resistance Level | $250.00 | $570.24 |
| Average True Range (ATR) | 8.27 | 25.96 |
| MACD | -1.38 | 0.77 |
| Stochastic Oscillator | 21.29 | 35.89 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Ubiquiti Inc is a seller of equipment and provides the related software platforms through web stores. The group develops technology platforms for high-capacity distributed Internet access, unified information technology, and consumer electronics for professional, home, and personal use. Its solutions are: high-performance networking technology for enterprises, service providers, and consumers. target the enterprise and service provider markets through a community of service providers, distributors, value-added resellers, webstores, systems integrators, and corporate IT professionals, which it refers to as the Ubiquiti Community. It targets consumers through digital marketing, including through webstores, retail chains, and, to a lesser extent, the Ubiquiti Community.